Results 1-5 of 5 (Search time: 0.003 seconds).
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas (Journal article)
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival (Journal article)
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme (Journal article)
Response and progression in recurrent malignant glioma (Journal article)
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy (Journal article)